LGALS3 methylation expression is associated with the loss of the galectin‐3 expression in the mucinous colorectal carcinomas,37 prostate cancer38 and breast cancer,39 suggesting that its expression is controlled in an epigenetic manner. Here, LGALS3 is linked to breast carcinoma.